A new market study, titled “Global Recombinant Vaccines Market Research Report 2018”, has been featured on WiseGuyReports.
This report studies the global Recombinant Vaccines market status and forecast, categorizes the global Recombinant Vaccines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease.
These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.
Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.
There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.
The global Recombinant Vaccines market is valued at 880 million US$ in 2017 and will reach 1400 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2018-2025.
The major manufacturers covered in this report
Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
Request Sample Report at https://www.wiseguyreports.com/sample-request/3317040-global-recombinant-vaccines-market-research-report-2018
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Recombinant Human Vaccines
Animal Recombinant Vaccines
The study objectives of this report are:
To analyze and study the global Recombinant Vaccines sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Recombinant Vaccines manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Recombinant Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Recombinant Vaccines Manufacturers
Recombinant Vaccines Distributors/Traders/Wholesalers
Recombinant Vaccines Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
1 Recombinant Vaccines Market Overview
2 Global Recombinant Vaccines Market Competition by Manufacturers
3 Global Recombinant Vaccines Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Recombinant Vaccines Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Recombinant Vaccines Production, Revenue (Value), Price Trend by Type
6 Global Recombinant Vaccines Market Analysis by Application
7 Global Recombinant Vaccines Manufacturers Profiles/Analysis
8 Recombinant Vaccines Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Recombinant Vaccines Market Forecast (2018-2025)
13 Research Findings and Conclusion
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
